At eight o'clock in the morning, Wei Kang walked into the office, opened the window, felt the fresh and pleasant air, and instantly felt refreshed.

The computer has automatically turned on and is quietly logging into the network.

In fifteen minutes, this industry conference that will have a major impact on the world is about to begin.

Attendees are all CEOs of the world's top ten multinational pharmaceutical companies, such as Pfizer, Novartis, Roche, Bayer, Merck, GSK, Gilead, etc.

It can be said that they are all giants who will cause a huge shock in the industry if they just stamp their feet.

Basically covers all the top original drug manufacturers in Europa and Eagle Country.

He was the host, and Sanqing was the only Chinese pharmaceutical company present.

Wei Kang took a deep breath. Unknowingly, he had reached this stage.

Not only has it become a leader in pharmaceutical companies in China, but also in the entire East Asia.

The strength is so strong that it can even resist the ten giants on its own.

If he were not in the game, but just a passerby, he might not be able to help but take a breath and utter the words "so scary".

"Mr. Wei, the meeting is about to start in five minutes."

Anmei's reminder sounded at the right time.

Wei Kang sat in front of the computer and saw that all participants had logged in.

In the small squares on the screen, strange Western faces, both male and female, were looking at the camera with solemn expressions.

Good guy, we've all arrived early and are waiting for him to start, Wei Kang thought to himself.

At this time, it is eight or nine o'clock in the evening in Eagle Country, while it is already past 12 o'clock in the morning in Europa.

It’s not that Wei Kang had to choose such a weird time, the main reason is that it’s difficult to coordinate the time zone issue and get an answer that satisfies all three parties.

Therefore, as the host, Wei Kang could only prioritize meeting his own needs and choose a time that was more convenient for him.

Others can only accommodate themselves, because they all want something from him.

Fortunately, these presidents all have rich experience in working across time zones, and all of them were fully prepared and attended on time.

When the time was up, the camera and microphone were turned on, and Wei Kang's face appeared in the center of the screen on time.

Everyone's faces were instantly filled with smiles, and they smiled and nodded to him as a sign of goodwill.

Wei Kang responded with a smile and announced the start of the meeting.

"Thank you all for coming to this meeting. Without further ado, let me first introduce HIV gene drugs in detail..."

"As we all know, there are more than 30 million AIDS patients in the world, one-third of which are in Europe, Eagle Country, Asia, Latin America and other places."

"The plans to end AIDS in various countries are being implemented steadily, and the progress is gratifying, and this new drug from Sanqing will undoubtedly be the last bullet."

"Unfortunately, Sanqing only has one biopharmaceutical factory with limited production capacity. It can only supply China within a short period of time and cannot cover all parts of the world."

"Recombinant genetic viruses not only have extremely high technical thresholds for production, but also require a cold chain for transportation and storage. The conditions are quite harsh. Sanqing does not yet meet the requirements in this regard, so we can only look for qualified ones around the world.

A strong and sincere collaborator.”

"There won't be too many collaborators, probably about 3-5, mainly responsible for markets outside China. I hope everyone can cooperate sincerely and establish long-term friendship."

…

"Eradicating AIDS requires the whole world to unite as one and work together. Only relying on the three clean-ups and one family can't achieve this great goal with only a small amount of money."

"Please believe me, Sanqing comes with a win-win attitude. We are willing to be the one who shares the cake and make the pharmaceutical industry bigger and stronger, rather than being the one who smashes the dishes."

"Everyone, what do you think?"

After saying this, Wei Kang looked at everyone and waited for them to speak.

He sighed secretly in his heart. Unfortunately, most AIDS patients are abroad and are really out of reach.

Moreover, this is a public health issue, and all prevention and control work is in the hands of national governments. It is completely different from diseases such as cancer and Alzheimer's disease, which are treated at their own expense.

If you want to make money from foreign HIV-infected people, you can't get around these local snakes.

Moreover, the production of biological agents is more complex than chemical pharmaceuticals and has a higher technical threshold.

This is not a rare disease that only affects tens of thousands of people worldwide. AIDS is a mass infectious disease.

Even if there are one million patients in the country, if everyone needs to take the medicine within a year, the production will still be 90,000 doses a month.

Not to mention the tens of millions of overseas patients, if Sanqing relied solely on its own production, I'm afraid there would be a ten-year war of resistance.

This greatly goes against his original intention of developing this drug.

And people all over the world certainly can’t wait.

He must make good use of the production capacity and technical personnel of these multinational giants, as well as the intricate relationships behind them.

Fortunately, this is a one-time cooperation. If we work with these giants to eradicate AIDS, it will be over, and there will be no further involvement.

The first person to speak was Pfizer CEO Albert, who emphasized his old friendship with Sanqing from the very beginning.

I saw a smile on his face, he smiled so hard that his teeth couldn't even see his eyes, and he said in a flattering tone.

"Pfizer and Sanqing have had a deep friendship for five years starting from anti-cancer drugs. It has been very smooth and has become a strategic partner. This time, we will definitely show the greatest sincerity and become Mr. Wei's best friend."

Everyone else's expressions darkened. With Pfizer's statement, it would be unrealistic to unite to lower prices.

At present, some pharmaceutical companies that have little market for anti-AIDS drugs are vaguely thinking of retreating.

Oscar and Emma looked at each other and quickly had a tacit understanding.

As the undisputed kings in the field of anti-AIDS drugs, GSK and Gilead were about to be killed by Sanqing's new drugs, but now they have this opportunity, which can be said to be a return to the past.

As long as the two of them grab the cooperation quota, they will have a buffer period, and they can smoothly transition to other directions while maintaining their market share.

With a hint of respect in his confidence, Oscar said with a smile: "Mr. Wei, Gilead currently occupies more than 60% of the anti-AIDS drug market. It has unique technology accumulation in the anti-viral field and has 6 genetic engineering pharmaceutical companies in the world.

Factory and 3 biological R&D centers, it has absolutely strong strength in the technical support and production of biopharmaceuticals."

"There are specialized industries, such as Johnson & Johnson and Bayer, which are very good pharmaceutical companies," he glanced at the other CEOs one by one with his unruly eyes, but when he looked at Wei Kang, he instantly became as docile as a puppy.

…

"But compared with Gilead, there is still a big gap between them in the field of anti-AIDS drugs. I believe Mr. Wei must understand this."

"If we are lucky enough to become the authorized partner of Sanqing, we will definitely be able to sell HIV genetic medicines to all parts of the world as soon as possible without sparing any patient."

"At the same time, we are also very experienced in price negotiations with various countries. As we all know, we also developed antiviral drugs for hepatitis C, which is also an infectious disease very similar to AIDS. The situation at that time was very similar to now, but

We did it, sold the drug all over the world, and completely cured hepatitis C patients in the West."

He kept a very low profile and showed off all his advantages as soon as he came up. He acted like I was very strong and capable, indicating that he would never suffer any loss if he came to me.

Wei Kang couldn't help but nod. Gilead's experience in eradicating hepatitis C seems to be very useful in eradicating AIDS.

Moreover, this company has a strong background and is inextricably linked to the major virus laboratories in Eagle Country.

GSK President Emma also quickly spoke and expressed her strong willingness to cooperate.

Wei Kang is also relatively satisfied with this pharmaceutical company representing Europa, which has rich experience and a broad market in the field of anti-AIDS.

Okay, just these three companies, Europa will give to GSK, Eagle Country will give to Gilead, and Third World will give to Pfizer.

He secretly made a division in his mind and gave the third world to Pfizer. In addition to its strong background, it was also related to Pfizer's corporate philosophy.

Unlike Sanqing, Pfizer is a profit-only pharmaceutical company, and the only criterion for measuring everything is Lilan.

This principle is clearly engraved in the corporate spirit and written in the company's articles of association.

If Pfizer did this domestically, it would definitely have a bad reputation, but overseas, it would be fine at all, and it would even become a favorite among capital.

It is quite useful for making money in other areas.

For example, selling anti-cancer drugs at high prices is Pfizer's specialty, and of course Gilead is not bad in this regard either.

Although Sanqing has the reputation of selling drugs at high prices overseas, to be honest, the bottom line is still much higher than that of these foreign capitalists.

For many drugs, such as painkillers, health care drugs, and even some genetic drugs for rare diseases, the prices Sanqing sells are not as exaggerated as the prices of anti-cancer drugs licensed to Pfizer.

After all, it is a dragon that crosses the river, and its foundation is limited. It cannot suck marrow and knock bones like a local snake, and do whatever it takes.

Therefore, when Wei Kang thought of licensing cooperation, he immediately thought of Pfizer.

Since we want to make money by selling medicines overseas, how can we do it if we don’t find an excellent capitalist to cooperate with us?

The meeting continued, and anyone with a discerning eye could see it.

Authorization cooperation will definitely fall to these three companies.

Others' bids also became listless.

Sure enough, at the end of the meeting, Wei Kang announced the results.

Sanqing will reach strategic cooperation with Pfizer, Gilead and GSK, authorizing these three companies to produce and sell HIV gene drugs outside China.

These three companies will be responsible for a series of follow-up expenses such as overseas clinical expenses, marketing and promotion expenses, production and transportation of new drugs.

As for the payment methods, all three are the same.

An upfront payment of US$1 billion, cumulative development and commercial milestone payments of up to US$2 billion, and future sales in licensed territories.
To be continued...